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The mammalian lung develops through branching morphogenesis which is controlled by growth factors, hormones,
and extracellular matrix proteins. We have evaluated the role of EGF-receptor signaling in lung morphogenesis by analyzing
the developmental phenotype of lungs in mice with an inactivated the EGF-receptor gene both in vivo and in organ
culture. Neonatal EGF-receptor-de®cient mice often show evidence of lung immaturity which can result in visible respira-
tory distress. The lungs of these mutant mice had impaired branching and de®cient alveolization and septation, resulting
in a 50% reduction in alveolar volume and, thus, a markedly reduced surface for gas exchange. The EGF-receptor inactiva-
tion also resulted in type II pneumocyte immaturity, which was apparent from their increased glycogen content and a
reduced number of lamellar bodies. The defective branching was already evident at Day 12 of embryonic development.
When explants of embryonic lungs from Day 12 embryos were cultured under de®ned conditions, the branching defect
in EGF-receptor-de®cient lungs was even more pronounced, with only half as many terminal buds as normal lungs. EGF
treatment stimulated the expression of surfactant protein C and thyroid transcription factor-1 in cultured normal lungs,
but not in EGF-receptor-de®cient lungs, suggesting that EGF-receptor signaling regulates the expression of these marker
genes during type II pneumocyte maturation. Taken together, our data indicate that signal transduction through the EGF
receptor plays a major role in lung development and that its inactivation leads to a respiratory distress-like syndrome.
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INTRODUCTION molecules with their de®ned expression patterns play im-
portant roles (Heine et al., 1990; Schuger et al., 1993; Minoo
and King, 1994). Although the pulmonary mesenchyme hasLung formation in mammals begins as an endodermal
been shown to be essential for branching morphogenesisbudding from the foregut which, in mice, is initiated at
(Alescio and Cassini, 1962), the mechanism of this induc-Embryonic Day 9 (Theiler, 1972). Lung development can
tion is poorly characterized. Whereas epithelial morphogen-be divided into embryonic (E9±11), pseudoglandular (E12±
esis is modulated by mesenchyme-derived entactin/nidogen16.5), canalicular (E17±18), and saccular (P1 onward) peri-
(Ekholm et al., 1994; Senior et al., 1996), the nature of theods, during which the developing bilateral tubules undergo
factors involved in these paracrine interactions remains torepetitive branching and give rise to the proximal bronchial
be further explored.portion of the adult lung and distal respiratory acini respon-
During normal cell differentiation in the lung, undifferen-sible for gas exchange (Ten-Have-Opbroek, 1991; Wert et
tiated cuboidal cells form the lining into the distal air spacesal., 1993). This branching morphogenesis occurs through
and differentiate into type I epithelial cells and type II alveo-well-orchestrated epithelial±mesenchymal interactions in
which growth factors, hormones, and extracellular matrix lar cells. Thin cytoplasmic extensions of type I cells line
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the alveolar walls, thereby covering most of the alveolar to enhance lung maturation in fetal rabbits (Catterton et
al., 1979) and to stimulate lung branching in fetal micesurface, and provide a short diffusion pathway for gas ex-
change. The type II cells are responsible for the production (Goldin and Opperman, 1980; Warburton et al., 1992;
Schuger et al., 1993), although contradictory results existand secretion of pulmonary surfactant, i.e., a heterogeneous
complex of phospholipids and apoproteins that provides the (Ganser et al., 1991). EGF also enhances the differentiation
of type II pneumocytes (Whitsett et al., 1987; Plopper et al.,low surface tension that prevents alveolar collapse. Four
different surfactant proteins, SP-A, -B, -C, and -D, exist; the 1992), which is consistent with their expression of EGF-R
(Raaberg et al., 1992). Furthermore, EGF de®ciency duringlethal phenotype resulting from inactivation of the SP-B
gene (Clark et al., 1995) illustrates their important role. perinatal development results in mild respiratory distress
syndrome and delayed lung maturation (Raaberg et al.,Surfactant protein synthesis correlates with and precedes
morphological maturation of type II pneumocytes. The ex- 1995). To evaluate the developmental role of the EGF-R, we
and others have recently inactivated the EGF-R gene bypression of SP-C mRNA starts at the late pseudoglandular
stage and is subsequently restricted to type II pneumocytes speci®c gene targeting (Miettinen et al., 1995; Sibilia and
Wagner, 1995; Threadgill et al., 1995). In two of these stud-(Glasser et al., 1990; Khoor et al., 1994). A novel gene, T1a,
with an as yet unknown function is at present the only ies and depending on the genetic background, EGF-R 0/0
mice often develop respiratory failure as a result of lungcell-speci®c marker for type I cells (Rishi et al., 1995). The
proximal airways, i.e., tracheal, bronchial, and bronchiolar immaturity (Miettinen et al., 1995; Sibilia and Wagner,
1995). We have now evaluated the involvement of the EGF-airways, also contain Clara cells or nonciliated bronchiolar
cells, which are an epithelial secretory cell type of unknown R in lung development using EGF-R 0/0 mice and show
impaired branching morphogenesis resulting in de®cient al-function.
Growth factors regulate the growth and development of veolization and septation. Furthermore, we also show that
the expression of SP-C and thyroid-speci®c transcriptionmany organs, including lung. Most growth factors signal
their mitogenic activities through tyrosine kinase receptors. factor (TTF-1), two markers of type II pneumocyte matura-
tion, is upregulated by EGF-R-mediated signaling. The ab-Perhaps the best studied member of this large receptor fam-
ily is the epidermal growth factor receptor (EGF-R) which sence of this regulation in the EGF-R 0/0 mice correlates
with the poor alveolization of their lungs.consists of a large cysteine-rich extracellular domain, a sin-
gle transmembrane segment, and a long cytoplasmic do-
main, which contains the 11 subdomains characteristic of
kinases (Ullrich et al., 1984; Schlessinger and Ullrich, 1992). MATERIALS AND METHODS
Several structurally related ligands, EGF, TGF-a, HB-EGF,
amphiregulin, and betacellulin, bind to the EGF-R and trig-
EGF Receptor-De®cient Miceger similar responses. Ligand binding leads to receptor di-
merization and autophosphorylation of the kinase domain. The EGF-R gene was inactivated by homologous recombination,
Subsequent recruitment of cytoplasmic effector proteins as described (Miettinen et al., 1995). Embryos and newborn pups
through their SH2 domains to the tyrosine-phosphorylated used in this study were derived from intercrosses between EGF-R
//0 mice in a Swiss-Webster genetic background. The plug datesites initiates signaling cascades which lead to cell prolifera-
was considered Day 0.5 of pregnancy. E12±15.5 embryos were geno-tion and differentiation (Schlessinger and Ullrich, 1992). In
typed by Southern blot analysis, whereas older EGF-R0/0 embryosaddition to homodimerization, the EGF-R can also undergo
and newborn animals could be reliably recognized from their open-ligand-induced heterodimerization with the closely related
eye phenotype. Newborn animals were sacri®ed by lethal injectionHER-2 and HER-3 receptors, thus increasing the diversity
of ketamine, and lungs were removed by dissection. Embryos wereof signal transduction pathways (Lemmon and Schlessinger,
collected at E12.5, 13.5, 14.5, 15.5, and 16.5 for histological analysis
1994). and at E12 for lung organ cultures.
Although no systematic survey has been done on where
the EGF-R and its ligands are expressed during lung morpho-
genesis, EGF-R has been localized in embryonic lung pri- Histology and Immunohistochemistry
mordia in the epithelial and mesenchymal components
(Partanen and Thesleff, 1987; Snead et al., 1989; Warburton Newborn lungs and embryos were ®xed in 4% paraformaldehyde
and processed into serial paraf®n sections using routine procedures.et al., 1992). Similarly, EGF is also expressed in both tissue
The cultured lungs were ®xed in Carnoy's ®xative. For histology,types of the developing lung, and TGF-a colocalizes with
the sections were stained with hematoxylin±eosin or periodic acidthe EGF-R in epithelial cells of saccules and smooth muscle
Schiff (PAS, with and without diastase), examined under the lightcells of bronchioles (Kubiak et al., 1992; Strandjord et al.,
microscope, and photographed. For immunohistochemistry, anti-1994). The colocalization of the EGF-R and its ligands in
bodies to proSP-C (gift from Drs. J. A. Whitsett and S. Wert) and
primitive airways during branching morphogenesis suggests TTF-1 (Minoo et al., 1995) were used as described (Miettinen et
an autocrine or paracrine role for these factors in lung devel- al., 1989). The speci®c immunoreactivities were detected using
opment (Warburton et al., 1992). peroxidase-conjugated donkey anti-rabbit immunoglobulins (Am-
Several lines of evidence suggest a direct role for EGF-R ersham) and DAB as a chromogen (Sigma). For electron microscopy
(EM), the lungs were ®xed overnight in 2% glutaraldehyde (Tedmediated signaling in lung maturation. EGF has been shown
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Pella), washed in PBS, dehydrated in a series of ethanol, and pro- cles of ampli®cation (1 min for denaturation at 947C, annealing
at 607C, and extension at 727C) (Zhao and Nishimoto, 1995). Thecessed for EM using routine procedures.
For morphometric analyses, serial sections of lungs from E12.5± reaction mixture (10 mM Tris, pH 9.4, 50 mM KCl, 2 mM MgCl2,
0.01% gelatin, 0.1% Triton X-100, 20 pmole of each primer, 10016.5 embryos and newborn EGF-R 0/0 mice and control lungs
from newborn EGF-R //0 or wild-type animals were stained with mM dNTP, known amounts of TTF-1, SP-C, or b-actin competi-
tor, and 0.5 unit of Hot Tub DNA polymerase, Amersham, Ar-hematoxylin±eosin and the images were scanned using NIH Image
program. The ratio of air-®lled space versus total lung area and the lington Heights, IL) was added to reverse-transcribed samples or
to dilutions of standard templates, i.e., TTF-1, SP-C, or b-actinnumber of interalveolar septi and alveoli were determined. Areas
were measured similarly in E12 lungs that were cultured for 4 days. cDNA. The expression of each mRNA was analyzed from six
different lung samples (n  6).
After PCR the samples were analyzed in 3% agarose gels (3:1
RNA Isolation and Northern Blot Analysis mixture of NuSieve and Seakem, FMC) to separate the target and
competitor PCR products. The visualized bands were densitomet-
Total RNA was isolated from snap-frozen lungs using Ultraspecx rically quantitated using ImageQuan band-analyzing software (Mo-
(Biogenex) according to the manufacturer's instructions. RNA sam- lecular Dynamics, Sunnyvale, CA). The logarithmic value of stan-
ples (30 mg) were electrophoretically separated in 1.2% formalde- dard/competitor products was plotted against the logarithm of the
hyde±agarose gels and electroblotted to Hybond-N (Amersham). initial amount of reverse-transcribed total RNA. The amounts of
The ®lters were hybridized for 2 hr in Quick-Hyb (Stratagene) with
b-actin, SP-C, and TTF-1 mRNA in the cultured lungs were ex-
randomly labeled cDNA probes at 687C, washed three times for 20 pressed in equivalents of target cDNA from the standard curve
min at 607C in 0.11 SSC±0.1% SDS, and exposed to Kodak X- (Zhao and Nishimoto, 1995). Statistical signi®cance was assessed
OMAT at 0707C for autoradiography. Human proSP-C and TTF-1 using Student's t test.
cDNAs were used as hybridization probes.
Embryonic Lung Cultures RESULTS
Pregnant mice were sacri®ced at Day 12 postcoitum and the E12
Impaired Alveolarization in Lungs of Newbornembryos were dissected. Genotyping was done as mentioned above.
EGF-R 0/0 MiceFetal lung primordia were isolated by microdissection and placed
into culture as described (Jaskoll et al., 1988; Warburton et al.,
We previously observed that the newborn mice with tar-1992). They were cultured in chemically de®ned medium con-
geted inactivation of the EGF-R displayed a heterogeneitysisting of Fitton-Jackson BGJb medium (GIBCO), 0.2 mg/ml
in size (Miettinen et al., 1995). The small mice often hadascorbic acid, and 50 units/mg penicillin/streptomycin (GIBCO).
breathing dif®culties associated with immature lung devel-The lungs were grown with or without 20 ng/ml mouse EGF
opment, which resembled respiratory failure in premature(Sigma) for 4 days with a change of medium every 2 days. After 4
days, the lungs were photographed and harvested for either im- human neonates. We have now examined in detail the lung
munohistochemistry or quantitative polymerase chain reaction phenotype and development in EGF-R 0/0 mice.
(Q-PCR). Lungs from four newborn EGF-R 0/0 mice and two size-
matched control littermates were serially sectioned for his-
tological and morphometric analyses. Among the four EGF-Q-PCR Analysis
R 0/0 pups, only one had visible respiratory problems, as
Individually cultured lung explants were homogenized in RNA- judged from the gasping breath and cyanotic skin color,
zol and total RNA was isolated according to manufacturer's in- while the three others did not behave differently from the
structions (Gibco). RNA was reverse transcribed as described (Zhao controls. Nevertheless, the lung phenotypes of all four EGF-
and Nishimoto, 1995) and the corresponding cDNA was subjected R 0/0 pups were clearly abnormal. Macroscopically, all
to quantitative PCR. The following primers were used: (1) TTF-1, lungs of EGF-R 0/0 mice had atelectatic areas and large
upstream 5*-GTC TAC GAG CTC GAG CGA CG-3* and down-
airways at periphery which were not observed in controlstream 5*-CTG GAA CCA GAT CTT GAC CTG C-3* spanning
littermates (Fig. 1A). On histology, a spectrum of morpholo-nucleotides 517±630 in the rat TTF-1 cDNA (Guazzi et al., 1990);
gies from collapsed or thick-walled alveoli to wide terminal(2) SP-C, upstream 5*-GG TCC TTG AGA TGA GCA TGC GT-3*
bronchi at the pleural edge was identi®ed (Figs. 1B and 1C).and downstream 5*-GTA GAG TGG TAG CTC TCC ACA C-3*
spanning nucleotides 1776±1777/2121±3049 in the mouse SP-C In general, the alveoli of the EGF-R0/0mice were irregular
genomic DNA corresponding to amino acids 67±201 in the mouse and hemorrhagic (Fig. 1C), which is in contrast to the regu-
proSP-C (Glasser et al., 1990); (3) b-actin, upstream 5*-GCT CTA larly shaped alveoli of control mice (Fig. 1D). These differ-
GAC TTC GAG CAG GAG A-3* and downstream 5*-GAT CTT ences in alveolar organization were readily apparent using
CAT GGT GCT AGG AGC C-3* spanning nucleotides 738±1061 phase-contrast microscopy. Whereas some areas of EGF-R
in the mouse b-actin cDNA (Tokunage et al., 1986). A known 0/0 lungs (Fig. 2B) had alveolar structures similar to those
amount of a standard competitor for each of the cDNAs (TTF-1,
of control lungs (Fig. 2A), other areas were strikingly differ-SP-C, and b-actin) was added to the PCR reactions. The competitor
ent, showing fewer septations, larger alveolar spaces, andconsisted of v-erbB cDNA (nucleotides 2586±2765) as a backbone
thinner interstitial tissue (Fig. 2).and the above mentioned gene-speci®c primer sequences at the 5*
Differentiation of type II pneumocytes is accompanied byand 3* ends (Bruskin et al., 1990).
PCR was done according to standard procedures using 35 cy- a reduction in cytoplasmic glycogen content and an increase
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FIG. 1. Structural immaturity in newborn EGF-R 0/0 lungs. (A) Macroscopically, EGF-R 0/0 lungs showed large atelectatic areas (white
arrows) or large airways close to the pleural surface (black arrow) creating a translucent appearance. (B) EGF-R 0/0 lungs stained using
periodic acid Schiff (PAS) stain for glycogen have wide terminal bronchi lined with numerous glycogen-positive red cells (black arrowheads)
which extend to the periphery. (C) EGF-R 0/0 lungs also had areas of collapsed and irregularly shaped alveoli with glycogen-containing,
PAS-positive cells). (D) In contrast to the EGF-R 0/0 lungs, control EGF-R //0 lungs had regularly shaped alveoli with cells that stained
only weakly for glycogen. Bar, 20 mm (B±D).
in lamellar body abundance (Ten-Have-Opbroek, 1991). We an abundance of glycogen-containing cells along the bron-
chi and alveolar walls of the EGF-R 0/0 lungs (Figs. 1B andtherefore used these characteristics to analyze the cell dif-
ferentiation in the four EGF-R 0/0 newborn pups and their 1C). The staining of control lungs for glycogen was much
weaker (Fig. 1D). Treating the sections with diastase abol-two normal littermates. PAS staining for glycogen revealed
FIG. 2. Phase-contrast microscopy of cryostat sections of the lungs of newborn control (A) and EGF-R 0/0 (B) mice. The area in (B)
showed fewer septations, larger alveolar spaces, and thinner interstitial tissue than in control alveoli (A). Bar, 200 mm (B).
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FIG. 3. Electron microscopic analysis of alveolar epithelial cells in control (A) and EGF-R 0/0 (B) lungs. EGF-R 0/0 alveolar epithelial
cells contained more glycogen (*) and fewer lamellar bodies than cells of control cells. Arrows mark the apical surface of epithelial cells.
Bar, 10 mm (A).
ished the staining, thus showing its speci®city for glycogen shown), presumably owing to the heterogeneity and differ-
ent cellular distribution in the EGF-R 0/0 lungs.(data not shown). Electron microscopic analysis also
showed that many, but not all, type II pneumocytes of EGF- To quantify the structural differences between EGF-R
0/0 and control lungs, we performed morphometric analy-R 0/0 lungs contained more glycogen storage granules and
fewer lamellar bodies than the control EGF-R //0 lungs sis on serial sections stained with hematoxylin±eosin. We
assessed the ratio of air-®lled space versus total lung area(Fig. 3), further suggesting epithelial immaturity.
Early during maturation, type II pneumocytes induce the and the number of intra-alveolar septa and alveoli per sur-
face area. The mean air-®lled area comprised 42% of theexpression of surfactant protein, and SP-C production is
considered a marker of mature type II cells. Since reduced lung area in the EGF-R 0/0 mice and 54% in controls.
Furthermore, the number of interalveolar septa was 24 perproduction of surfactant proteins is associated with respira-
tory failure of the neonate, we also analyzed the newborn unit surface area in the EGF-R0/0 lungs, while in the same
size area the control lungs contained 60 septa. These areaslungs for expression of SP-C protein and mRNA. By immu-
nohistochemistry, the EGF-R//0 control lungs showed SP- also had fewer air-®lled alveoli in the EGF-R 0/0 animals
compared to the controls (91 vs 125). This was particularlyC-immunoreactive epithelial cells in most alveoli. In con-
trast, the EGF-R 0/0 lungs contained both areas without evident in the gasping EGF-R 0/0 newborns. On average,
the EGF-R0/0 lungs had one intra-alveolar septum per fourSP-C-like immunoreactivity and areas with intensely stain-
ing SP-C-immunoreactive cells. However, there were no alveoli, whereas in controls the ratio is one septum per two
alveoli. The proliferation of mesenchymal and epithelialoverall quantitative differences between control and EGF-
R 0/0 lungs by Western or Northern analysis (data not cell populations in the newborn lung was studied by in
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FIG. 4. Lung branching morphogenesis during embryonic development. (A, B) At E12.5, the lung development in EGF-R 0/0 mice was
already impaired, since EGF-R 0/0 lungs (B) have 34% fewer tubules than EGF-R //0 lungs (A). (C, D) At E14.5, the bronchi of the
control embryos had further branched and given rise to subsegmental bronchial tubules (C). In contrast, the EGF-R 0/0 lungs had sparser
bronchial trees containing 30% fewer tubules and still had abundant interstitial mesenchyme (D). (E, F) At E15.5, the lungs of control
mice (E) continued to branch, resulting in more acinar tubules and terminal sac-like structures (arrowheads) than in EGF-R 0/0 lungs
(F). (G, H) At E16.5, lungs of control mice (G) have considerably more branching than the EGF-R 0/0 lungs (H). Acinar tubules and sacs
of the wild-type and EGF-R //0 lungs were already lined with low columnar/cuboidal epithelium, while the EGF-R 0/0 lungs still had
a visibly sharp demarcation (arrows) between the columnar and cuboidal epithelium far distal into the nascent pulmonary acinus. These
acini in the EGF-R 0/0 lungs (H) were also abnormally dilated compared with the acini in control lungs (G). Bar, 30 mm.
vivo BrdU injections and subsequent incorporation into the ment of EGF-R 0/0 mice and their control littermates at
different embryonic stages. In E12.5 embryos, i.e., duringDNA of proliferating cells. No signi®cant differences in
DNA labeling were noted (data not shown). the pseudoglandular stage when the primary bronchi branch
to secondary bronchi and lobe formation is initiated, the
branching morphogenesis in the EGF-R 0/0 lungs was al-
Impaired Embryonic Lung Development in EGF-R ready defective, when compared to that of normal lit-0/0 Mice termates at this stage (Figs. 4A and 4B). The EGF-R 0/0
lungs contained 34% fewer primordial tubules and thereBecause the EGF-R 0/0 newborn lungs had characteris-
tics of impaired alveolarization and showed evidence of epi- was considerably less branching. At E14.5, the lungs of con-
trol embryos had already progressed through the pseudo-thelial immaturity, we next evaluated the lung develop-
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FIG. 5. Differential growth and branching in cultured E12 lung explants. Embryonic mouse lung explants from E12 control (A, B) and
EGF-R 0/0 (C, D) embryos were grown in culture. After 4 days in culture, the control (A) and EGF-R 0/0 (C) lungs had the same size
when grown in the absence of EGF. However, EGF-R 0/0 lungs had only half as many peripheral terminal buds as control lungs (35 { 3
versus 76 { 12 buds) and they were large and dilated (arrow, C) compared to the normal shape and smaller size in control lungs (arrow,
A). When cultured for 4 days in the presence of EGF (B, D), the number of branches in control lungs nearly doubled from 76 { 12 in the
absence of EGF to 126 { 2 in the presence of EGF, and no effect of EGF was apparent in EGF-R 0/0 lungs. Furthermore, the presence of
EGF resulted in an increase in lung size of about 1.4-fold in control lungs (B), whereas EGF-R 0/0 lungs retained the same size (D).
glandular stage as the secondary bronchi had further model for studying lung development under de®ned condi-
tions (Jaskoll et al., 1988; Warburton et al., 1992). To studybranched and given rise to subsegmental bronchial tubules
(Fig. 4C). In contrast, the EGF-R0/0 lungs had sparser bron- the role of the EGF-R in branching morphogenesis, we pre-
pared organ cultures from E12 control and EGF-R 0/0chial trees with abundant mesenchyme reminiscent of the
early pseudoglandular period (Fig. 4D). Toward the canalicu- lungs. E12 embryos were collected from timed natural preg-
nancies and the lungs were dissected out and placed intolar period (E15±16), the lungs of control EGF-R //0 mice
continued to branch (Fig. 4E) and had considerably more organ culture. The remainder of the embryo tissue was ge-
notyped by Southern analysis. At this stage, 18/91 embryosacinar tubules and sac-like terminal buds than the EGF-R
0/0 lungs (Fig. 4F). Furthermore, the derivative structures (19.8%) were EGF-R 0/0. The lung rudiments were placed
in serum-free medium in the presence or the absence ofof the acinar tubules of the wild-type and EGF-R //0 em-
bryos were already lined with low columnar and cuboidal EGF (20 ng/ml) for 4 days. They were then evaluated for
their extent of branching and subjected to quantitative PCRepithelium fairly distal in the periphery of the forming pul-
monary acinus (Figs. 4G and 4H). In addition, the acini in or histological and immunohistochemical analyses. As
shown in Fig. 5, both the EGF-R 0/0 (Fig. 5C) and controlthe EGF-R 0/0 lungs were more dilated than those in con-
(Fig. 5A) lungs had the same overall size when grown introl lungs, thus re¯ecting the poor branching morphogene-
the absence of EGF. However, only half as many peripheralsis. These developmental differences in embryonic lungs
terminal buds were present in EGF-R 0/0 lungs when com-further emphasize the impaired development associated
pared with control lungs (35 { 3 buds versus 76 { 12, Tablewith lack of EGF-R signaling.
1). Furthermore, the terminal buds of the cultured EGF-R
Embryonic Day 12 EGF-R 0/0 Lungs Branch 0/0 lungs were large and dilated instead of small and regu-
Poorly in Vitro lar in shape (Figs. 5A and 5C). This difference in branching
Embryonic mouse lung explants undergo morphogenesis became more pronounced when the lungs were cultured in
the presence of EGF. Whereas the EGF-R0/0 lungs retainedand cell differentiation in culture, thus providing a useful
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TABLE 1
Analysis of the Embryonic Lung Explant Cultures of EGF-R 0/0 and Control Littermate Lungs
E12 / 4 cultured EGF-R /// lung E12 / 4 cultured EGF-R 0/0 lung
(n  6) (n  6)
Number of branches
Untreated 76 { 12 35 { 3
With EGF 20 ng/ml 126 { 2 34 { 4
Difference in lung size after EGF treatment 1.41 11
SP-C/b-actin mRNA
Untreated 100 { 23.6 148 { 49.2
With 20 ng/ml EGF 1470 { 248 187 { 68.7
TTF-1/b-actin mRNA
Untreated 100 { 19.8 127 { 32.0
With 20 ng/ml EGF 294 { 26.7 106 { 21.6
Note. Embryonic lungs from E12 EGF-R 0/0 and wild-type mouse embryos were cultured for 4 days without or with EGF (20 ng/ml).
They were then scored for branching, size, and the expression of SP-C and TTF-1 mRNA (as assessed by RT±PCR and normalized to
expression of b-actin mRNA in as arbitrary units). Results are shown as means { SD (n  6 lungs). The baseline expression of SP-C/b-
actin mRNA and TTF-1/b-actin mRNA in the control lungs is marked as 100. Statistical signi®cance was assessed using Student's t test
(P  0.05).
the same size and number of terminal branches (Fig. 5D), DISCUSSION
the size of the control lungs (Fig. 5B) increased 1.4-fold and
the number of branches nearly doubled (from 76 { 12 to To characterize the role of EGF-R signaling in lung devel-
126 { 2). opment, we have studied the lung phenotype of EGF-R
To evaluate the degree of cell differentiation of the cul- 0/0 mice. Targeted inactivation of functional EGF-R sig-
tured lungs, we analyzed the expression of SP-C as a differ- naling resulted in impaired alveolization and lung function.
entiation marker for pre-alveolar type II cells (Glasser et al., A delay in branching morphogenesis was already evident at
1990) and the expression of TTF-1 as a differentiation the early stages of lung development starting at E12.5. This
marker of epithelial cells of the developing airways (Lazzaro delay was maintained and gradually increased as the em-
et al., 1991). The mRNA levels for these markers were as- bryos developed. Consistent with the defective branching
sessed using quantitative PCR normalized to b-actin expres- morphogenesis, the EGF-R 0/0 lungs contained fewer ter-
sion (Fig. 6, Table 1). TTF-1 mRNA expression was slightly minal buds, which was best evaluated in organ cultures of
elevated but not signi®cantly higher in the EGF-R 0/0 E12 lungs. After 4 days in culture, the EGF-R 0/0 lungs
lungs than in the control lungs (127% { 32 vs 100% { 20). had only about half of the terminal buds when compared
As expected, the EGF-R 0/0 lungs were unresponsive to to EGF-R //0 lungs. This result is consistent with previous
EGF and the TTF-1 mRNA level did not change after EGF studies showing that lung branching morphogenesis is stim-
stimulation. In contrast, addition of EGF to the culture me- ulated by EGF and amphiregulin (Goldin and Opperman,
dium resulted in a 2.9-fold increase in TTF-1 mRNA expres- 1980; Warburton et al., 1992; Schuger et al., 1996) and inhib-
sion in the control lungs (P  0.05, Table 1). Immunohisto- ited by EGF antisense oligonucleotides (Seth et al., 1993)
chemistry revealed nuclear TTF-1- staining in the control or antibodies to amphiregulin (Schuger et al., 1996). Consis-
lungs, whereas the EGF-R 0/0 lungs were almost devoid tent with the embryonic EGF-R 0/0 phenotype, the num-
of detectable TTF-1 staining (Fig. 7). Expression of SP-C ber of alveoli in newborn EGF-R 0/0mice was also consid-
mRNA was also evaluated by quantitative PCR. SP-C erably lower than that in the control littermates. This differ-
mRNA levels were not signi®cantly elevated in the EGF-R ence was 27% based on measurements in two-dimensional,
0/0 lungs under basal culture conditions compared with histological sections, resulting in a calculated 52% smaller
control lungs (148% { 49 vs 100% { 23; P  0.05) and alveolar volume of the lungs of the EGF-R 0/0 mice, even
did not change following EGF treatment. In contrast, EGF in those without visible respiratory distress. This greatly
clearly upregulated SP-C mRNA expression in control lungs reduced surface for gas exchange, combined with our obser-
(15-fold increase, P  0.05), as shown in Fig. 6 and Table vations that many of the alveoli in EGF-R 0/0 mice have
1. Consistent with these results, the upregulation of SP-C thicker alveolar walls or are collapsed and hemorrhagic,
mRNA after EGF stimulation also correlated with increased explains the variable breathing dif®culties seen with EGF-
SP-C-like immunoreactivity in the control lungs (Figs. 8A R 0/0 pups.
and 8B), whereas in EGF-R 0/0 lungs the intensity of the The immaturity of the EGF-R 0/0 lungs, as seen with
the structural abnormalities, was also re¯ected at the levelstaining remained the same (Fig. 8C).
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FIG. 6. Quantitative RT±PCR analysis of SP-C mRNA and TTF-1 mRNA expression in cultured E12 lungs. Control and EGF-R 0/0
lung explants were cultured for 4 days in the presence or the absence of EGF. Lung RNA was then isolated and subjected to quantitative
RT±PCR in the presence of a known amount of competitor DNA as described under Materials and Methods. The visualized bands (A±
C) were densitometrically quantitated and the ratios of TTF-1/competitor DNA, SP-C/competitor DNA, and b-actin/competitor DNA
re¯ect the amount of target RNA present in the lung. Thus, TTF-1 mRNA (A) and SP-C mRNA (B) were upregulated by EGF in control
(WT) lungs, but not in EGF-R 0/0 lungs. Equal levels of b-actin DNA (C) represent an internal control for successful reverse transcription
of the RNA sample. In D, the relative amounts of SP-C/b-actin mRNA and TTF-1 mRNA/b-actin mRNA in the cultured lungs, as assessed
from the RT±PCR analyses, are shown as bar graphs. Results are expressed as the mean { SD (n  6 individual lungs). Statistical values
were calculated using Student's t test (*P  0.05).
of epithelial cell differentiation. Type II pneumocyte differ- development and in bronchial epithelium at later stages of
lung development (Lazzaro et al., 1991). TTF-1 expressionentiation is normally accompanied by a reduction in cyto-
plasmic glycogen content and an increase in the number of has been shown to be essential for lung epithelial morpho-
genesis both in vitro using antisense oligonucleotides (Mi-lamellar bodies. Histological and electron microscopy anal-
yses revealed that, in contrast with the EGF-R //0 lungs, noo et al., 1995) and in vivo by targeted disruption of the
TTF-1 gene (Kimura et al., 1996). In the E12 lung cultures ofthe EGF-R 0/0 lungs contained more glycogen-positive
cells along the bronchi and alveolar walls and frequently normal embryos, EGF upregulated the TTF-1 mRNA level
threefold. Surfactant protein promoters have TTF-1 consen-had an increased number of glycogen storage granules and
fewer lamellar bodies in their type II pneumocytes. We sus binding sites and TTF-1 has been shown to activate
transcription from the SP-A, -B, and -C promoters (Bohinskitherefore conclude that type II pneumocyte differentiation
is impaired in EGF-R 0/0 lungs and, thus, that normal et al., 1994; Bruno et al., 1995), thus raising the possibility
that the EGF-R-induced upregulation of SP-C transcriptiondifferentiation of these cells requires activation of EGF-R
signaling. The observation that epithelial differentiation is is mediated in part by TTF-1. The increase in SP-C and
TTF-1 expression by EGF was seen in control lungs both atdecreased is consistent with previous ®ndings that exoge-
nous EGF promotes structural and functional differentia- the mRNA and protein levels, although the immunohisto-
chemical staining did not show as strong an induction, astion of type II pneumocytes (Whitsett et al., 1987; Plopper
et al., 1992), whereas antiserum to EGF blocks their matura- would have been suggested by the quantitative PCR experi-
ments. This mild discrepancy could be due to the qualita-tion (Yasui et al., 1993). Furthermore, our organ culture
experiments illustrate that the expression of SP-C mRNA tive nature of immunohistochemistry, differences in sensi-
tivities of the two methods, or to changes in mRNA stabil-and protein is increased in the presence of EGF, which sug-
gests that the expression of this marker gene of type II pneu- ity or translation ef®ciency.
From our studies, it is unclear whether the defect in alveo-mocyte differentiation is regulated by EGF-R signaling.
We also evaluated the expression of the transcription fac- lar branching results from defective signaling by the pulmo-
nary mesenchyme or epithelium or both. Tissue recombina-tor TTF-1, which is expressed during early stages of lung
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FIG. 7. TTF-1 immunostaining in cultured E12 lungs. Control lungs (A, C) and EGF-R 0/0 (B, D) lungs cultured for 4 days in the
presence of EGF were stained using a TTF-1-speci®c antibody. Control lungs show intense TTF-1 immunostaining in the nuclei of the
epithelial cells (A, C), which is largely absent in the EGF-R 0/0 lung explants cultured under the same conditions (B, D).
tion studies have implicated mesenchyme as inducer of epi- al., 1992) suggests that the mesenchyme might provide li-
gands which induce EGF-R signaling in the epithelial cells.thelial branching (Alescio and Cassini, 1962). Thus, the
distal pulmonary mesenchyme is able to induce in denuded Tissue recombination studies using EGF-R 0/0 and control
tissues should help provide insight into the inductive hier-bronchioli a normal branching pattern with cell differentia-
tion of the tracheal epithelium, whereas the absence of mes- archy during lung development.
The impaired epithelial maturation and lung develop-enchyme results in lack of branching and epithelial cell
death (Shannon, 1994). Interestingly, fetal rat pulmonary ment in our EGF-R 0/0 mice contrasts with the much
milder phenotype of waved-2 mice in which EGF-R signal-epithelium undergoes proliferation and differentiation in
the absence of mesenchyme, when cultured in the presence ing is impaired (Luetteke et al., 1994; Fowler et al., 1995).
In fact, no defects in lung development have been reportedof various growth factors such as EGF and aFGF (Deterding
and Shannon, 1995). Therefore, soluble factors released by in these mice. It should, however, be emphasized that there
is a clear difference between the defects in the EGF-R genesthe mesenchyme or extracellular matrix components might
be essential for normal structural and functional develop- of the waved-2 and EGF-R 0/0 mice. In the former mouse
strain, the EGF-R is expressed as a full-size receptor withment of the lung. The localization of EGF expression in
pulmonary mesenchyme (Snead et al., 1989; Warburton et ligand binding ability and a point mutation in the cyto-
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plasmic domain, which impairs but does not abolish the
kinase activity (Luetteke et al., 1994; Fowler et al., 1995).
Thus, a low level of receptor signaling is likely to occur and
both EGF-R homodimers and heterodimers of the EGF-R
with the related receptors HER-2 and HER-3 (Lemmon and
Schlessinger, 1994) are likely to be formed, similarly to the
wild-type situation. In contrast, EGF-R 0/0 mice lack re-
ceptor expression, thereby abolishing any signaling not only
by EGF-R homodimers, but also by the heterodimers.
The impaired lung development in the EGF-R 0/0 mice
often results in visible respiratory failure, as manifested by
gasping breathing and sudden death. This phenotype resem-
bles respiratory distress syndrome in humans, which is fre-
quently associated with premature birth. Premature infants
have both structural and functional lung immaturity which
leads to respiratory distress syndrome and bronchopulmo-
nary dysplasia. A major contributor to these diseases is the
low production of surfactant proteins by type II pneumo-
cytes coupled with epithelial immaturity of the lungs. Lack
of exposure to growth factors which in utero are normally
provided by amniotic ¯uid may further exacerbate the de-
fect. Oligohydramnion, i.e., too little amniotic ¯uid, results
in hypoplastic lungs and maturation arrest which particu-
larly affects the peripheral part of the acini (Wigglesworth
et al., 1981). This suggests that amniotic ¯uid contains an
essential factor(s) for lung growth and differentiation. Our
results, together with the fact that amniotic ¯uid contains
high levels of TGF-a and/or EGF (Barka et al., 1978; Weaver
et al., 1988; Goodyer et al., 1991), suggest that activation
of EGF-R signal transduction by amniotic ¯uid may play
an important role in embryonic lung development and that
the inactivation of the EGF-R may contribute to the lung
immaturity of EGF-R0/0mice. Thus, it is conceivable that
prematurely born infants might have a dysfunction of the
EGF-R due to insuf®cient amounts of EGF-R ligands. Such
an interpretation would be consistent with the phenotype
of our EGF-R 0/0 mice and several previous observations.
Indeed, EGF de®ciency during perinatal development in rats
results in mild respiratory distress syndrome and delayed
lung maturation (Raaberg et al., 1995). More importantly,
infusion of EGF in utero into fetal lambs and rhesus mon-
keys rescues prematurely born animals from respiratory dis-
tress syndrome (Sundell et al., 1980; Goetzman et al., 1993).
Thus, our results supported by previous studies suggest a
direct involvement of EGF-R signaling in lung development.FIG. 8. SP-C immunostaining in cultured E12 lungs. E12 control
As we learn more about the normal requirements and func-and EGF-R 0/0 lung explants were cultured for 4 days in the pres-
ence or absence of EGF. (A) Control lungs cultured in the absence tion of the EGF-R and its ligands during murine lung devel-
of EGF contain ducts and regularly shaped terminal buds, some of opment, we will hopefully also gain more insight into the
which stain strongly with anti- SP-C (brown color, black arrow), basis of human respiratory distress syndrome.
whereas others are not SP-C immunoreactive (white arrow). (B)
Addition of EGF to the culture medium resulted in a doubling of
the number of terminal buds and increased the SP-C immunoreac-
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